BIM
PRPH

BlackRock Investment Management’s ProPhase Labs PRPH Stock Holding History

BlackRock Investment Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-189
Closed -$2K – 4181
2015
Q1 		$2K Hold
189
– – ﹤0.01% 3983
2014
Q4 		$3K Hold
189
– – ﹤0.01% 4006
2014
Q3 		$3K Hold
189
– – ﹤0.01% 3977
2014
Q2 		$3K Buy
+189
New +$3.5K ﹤0.01% 3968

Other funds holding PRPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VIP
Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock Investment Management's PRPH Position: Q2 2015 in Review

BlackRock Investment Management sold out of ProPhase Labs (PRPH) in Q2 2015, closing a stake of 189 shares — an estimated $2K sold.

BlackRock Investment Management first reported a position in PRPH in Q2 2014 and held it in 4 quarters. The position peaked at $3K in Q4 2014. 13 funds tracked by Wall St. Rank hold PRPH as of Q2 2015.

  • BlackRock Investment Management reported no remaining ProPhase Labs position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 189 ProPhase Labs shares in Q2 2015, an estimated $2K.
  • BlackRock Investment Management first reported a position in ProPhase Labs in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's ProPhase Labs position peaked at $3K in Q4 2014.
  • 13 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.